Home / Recalls / Nephron Sc Inc / D-0175-2023

D-0175-2023 Class II Terminated

Recalled by Nephron Sc Inc — West Columbia, SC

Recall Details

Product Type
Drugs
Report Date
February 1, 2023
Initiation Date
January 13, 2023
Termination Date
October 11, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
387,000 vials

Product Description

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4

Reason for Recall

Short Fill

Distribution Pattern

Nationwide within the United States including Puerto Rico. Guatamala

Code Information

Lot #: 126451 Exp. 04/30/2023

Other recalls by Nephron Sc Inc

  • D-0364-2023 Class II — Sterile Water for Injection, USP, 30x5 mL Single-Dose Vials, Rx Only, Nephron 45 (February 23, 2023)
  • D-0176-2023 Class II — S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Steril (January 13, 2023)
  • D-0178-2023 Class II — Sterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose Vi (January 12, 2023)
  • D-0177-2023 Class II — 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, (January 12, 2023)
  • D-1354-2022 Class II — Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL si (August 10, 2022)